ACORDA THERAPEUTICS
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FD... A) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.
ACORDA THERAPEUTICS
Industry:
Biotechnology Developer Platform Health Care
Founded:
1995-01-01
Address:
Hawthorne, New York, United States
Country:
United States
Website Url:
http://www.acorda.com
Total Employee:
251+
Status:
Active
Contact:
(914) 347-4300
Email Addresses:
[email protected]
Total Funding:
151.6 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Mobile Non Scaleable Content HSTS IPv6 Cloudflare Hosting JsDelivr Apache Cloudflare JS CDN JS
Similar Organizations
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-19 | Biotie Therapies | Biotie Therapies acquired by Acorda Therapeutics | 363 M USD |
| 2014-09-24 | Civitas Therapeutics | Civitas Therapeutics acquired by Acorda Therapeutics | 525 M USD |
| 2012-02-17 | Neuronex | Neuronex acquired by Acorda Therapeutics | N/A |
Investors List
Paul Capital
Paul Capital investment in Post-IPO Equity - Acorda Therapeutics
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Acorda Therapeutics
New York State Department of Health
New York State Department of Health investment in Grant - Acorda Therapeutics
Cross Atlantic Partners
Cross Atlantic Partners investment in Series B - Acorda Therapeutics
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series B - Acorda Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Acorda Therapeutics
MPM Capital
MPM Capital investment in Series B - Acorda Therapeutics
Techno Venture Management
Techno Venture Management investment in Series B - Acorda Therapeutics
Forward Ventures
Forward Ventures investment in Series B - Acorda Therapeutics
ABN AMRO Fund
ABN AMRO Fund investment in Series B - Acorda Therapeutics
Official Site Inspections
http://www.acorda.com Semrush global rank: 2.9 M Semrush visits lastest month: 5.6 K
- Host name: 44.233.12.198.host.secureserver.net
- IP address: 198.12.233.44
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Acorda Therapeutics"
Acorda Therapeutics - Crunchbase Company Profile
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis …See details»
Acorda Online Reports - Letter from the ceo
Acorda’s Leadership Team, Board of Directors, and associates took decisive actions in 2017, and as a result Acorda has emerged in 2018 as a streamlined organization with a strong cash …See details»
Acorda Therapeutics - The Org
Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of …See details»
Org Chart Acorda Therapeutics - The Official Board
The organizational chart of Acorda Therapeutics displays its 10 main executives including Ron Cohen and Michael Gesser. Toggle navigation The Official Board. Search. Search. Search by …See details»
Acorda Therapeutics Company Profile 2024: Valuation, …
Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is …See details»
Acorda Therapeutics Board of Directors | Acorda.com
Acorda Therapeutics has been recognized as one of the Best Companies to Work for in New York State seven years in a row (2011-2017), among the Fortune 100 Best Medium-Size …See details»
Acorda Therapeutics Company Profile, Stock Price, …
Company Information Company Info Millennials In The Organization Women In The Organization. Company Information. ... https://www.acorda.com; Date info provided (companies may opt to keep some data ...See details»
Acorda Therapeutics, Inc. - Devex
Learn more about Acorda Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Everything they do is aimed at improving lives Millions of people with ...See details»
ACORDA THERAPEUTICS, INC. CORPORATE GOVERNANCE …
ACORDA THERAPEUTICS, INC. CORPORATE GOVERNANCE GUIDELINES. The board of directors (the “Board”) of Acorda Therapeutics, Inc. (the “Company”) has adopted the following …See details»
Acorda Therapeutics Inc Company Profile - Overview - GlobalData
Acorda Therapeutics Inc (Acorda), is a biopharmaceutical company that discovers, develops, and markets therapies for treating patients with neurological disorders. The company's portfolio …See details»
CODE OF ETHICS - Acorda Therapeutics
Acorda managers and supervisors have a special responsibility to maintain and communicate this Code consistently. They must create a work environment that encourages ethical behavior and …See details»
Acorda Therapeutics, Inc. Information - RocketReach
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of …See details»
Acorda Therapeutics - 2019
ACORDA, ACORDA THERAPEUTICS, the stylized ACORDA THERAPEUTICS LIFE. SCIENCE. mark, AMPYRA, INBRIJA, the INBRIJA logo, ARCUS, THE MANY FACES OF OFF, Live Well.See details»
Ron Cohen, M.D. - Advanced Therapeutics in Movement
Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including …See details»
Acorda Therapeutics - Overview, News & Similar companies
Aug 9, 2024 Acorda Therapeutics contact info: Phone number: (914) 347-4300 Website: www.acorda.com What does Acorda Therapeutics do? Founded in 1995, Acorda Therapeutics …See details»
Scientific Excellence - acorda.com
At Acorda Scientific Excellence Our goal is to be the leading biopharmaceutical company developing and marketing therapies that improve, repair, and restore neurological function in …See details»
Acorda Online Reports - ARCUS® Technology - Acorda Therapeutics
In 2015, the Bill & Melinda Gates Foundation awarded Acorda a $1.4 million grant to explore development of a formulation and delivery system for a dry powder version of lung surfactant, …See details»
Acorda - Overview, News & Similar companies | ZoomInfo.com
Acorda inks $185M asset sale with Merz, files for bankruptcy after years of disappointing sales After years of struggling with hurdles such as generic competition and significantly lower-than …See details»
Working At Acorda
Working At Acorda. Acorda Therapeutics, Inc. has been recognized as one of the "Best Companies to Work for in New York" and named to the "Deloitte Technology Fast 500 ™" for …See details»